SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5.01 |
| Enterprise Value ($M) | 0.98 |
| Book Value ($M) | 1.81 |
| Book Value / Share | 1.73 |
| Price / Book | 2.77 |
| NCAV ($M) | 1.77 |
| NCAV / Share | 1.69 |
| Price / NCAV | 2.83 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -38.48 |
| Return on Assets (ROA) | -0.77 |
| Return on Equity (ROE) | -1.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.73 |
| Current Ratio | 1.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.20 |
| Assets | 5.24 |
| Liabilities | 3.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -18.25 |
| Net Income | -75.34 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -14.30 |
| Cash from Investing | 2.81 |
| Cash from Financing | 5.97 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Bailey Gregory | 10.10 | -99.97 | |
| 13G/A | Armistice Capital, Llc | 4.99 | -97.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,820 | 16,120 | 11.29 | |
| 4,849 | 21,452 | 22.60 | |
| 3,713 | 21,118 | 17.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PROK – ProKidney Corp. | PRPH – ProPhase Labs, Inc. |
| PRQR – ProQR Therapeutics N.V. | PTIX – Protagenic Therapeutics, Inc. |
| PTPI – Petros Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io